ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT06614673

Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study

Launched by GERMAN CANCER RESEARCH CENTER · Sep 24, 2024

Apply for Trial

Trial Information

Current as of March 23, 2025

Enrolling by invitation

Keywords

Cancer Cancer Literacy Informational Intervention Health Communication

ClinConnect Summary

The online survey can be accessed through a unique link or QR code and is compatible with various electronic devices such as PCs, tablets, and smartphones. Reminders will be sent after one month and two months. Participants can also request a paper questionnaire if needed. We will make an effort to contact more people from districts with lower socioeconomic status. Furthermore, the study cover letter will disclose that all study participants will receive ten euros if they provide their bank details after completion of the study questionnaires. Participants will be redirected via a link to a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Between 18 and 70 years old
  • • Being able to speak and understand german
  • Exclusion Criteria:
  • • Not being able and willing to provide informed consent and complete questionnaires

Trial Officials

Karen Steindorf, Prof. Dr.

Principal Investigator

German Cancer Research Center

Alexander Haussmann, Dr.

Principal Investigator

German Cancer Research Center

Florian Herbolsheimer, Dr.

Principal Investigator

German Cancer Research Center

About German Cancer Research Center

The German Cancer Research Center (DKFZ) is a leading biomedical research institution dedicated to advancing cancer research and its application in clinical settings. Located in Heidelberg, DKFZ conducts innovative studies aimed at understanding the complexities of cancer biology, developing novel therapeutic strategies, and improving patient outcomes. As a prominent clinical trial sponsor, the center collaborates with national and international partners to facilitate cutting-edge research, translating scientific discoveries into effective treatments. With a commitment to excellence and a multidisciplinary approach, DKFZ plays a pivotal role in the global fight against cancer.

Locations

Heidelberg, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0